About
Evecxia Therapeutics develops proprietary drug delivery technologies to amplify serotonin synthesis through 5-HTP-based therapeutics for treating mental illnesses inadequately addressed by current antidepressants.
Explore Evecxia Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.